267 related articles for article (PubMed ID: 21051857)
1. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
Allington TM; Schiemann WP
Cells Tissues Organs; 2011; 193(1-2):98-113. PubMed ID: 21051857
[TBL] [Abstract][Full Text] [Related]
2. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.
Allington TM; Galliher-Beckley AJ; Schiemann WP
FASEB J; 2009 Dec; 23(12):4231-43. PubMed ID: 19690215
[TBL] [Abstract][Full Text] [Related]
3. Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG; Taylor MA; Schiemann WP
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
[TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
[TBL] [Abstract][Full Text] [Related]
7. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ; Schiemann WP
Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
[TBL] [Abstract][Full Text] [Related]
8. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
[TBL] [Abstract][Full Text] [Related]
9. Role of TGF-β and the tumor microenvironment during mammary tumorigenesis.
Taylor MA; Lee YH; Schiemann WP
Gene Expr; 2011; 15(3):117-32. PubMed ID: 22268294
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
11. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Kim H; Choi JA; Kim JH
J Biol Chem; 2014 Aug; 289(32):22151-60. PubMed ID: 24990945
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK; Smith JA; Schiemann WP
Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
[TBL] [Abstract][Full Text] [Related]
13. C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition.
Lourenço AR; Roukens MG; Seinstra D; Frederiks CL; Pals CE; Vervoort SJ; Margarido AS; van Rheenen J; Coffer PJ
Nat Commun; 2020 Feb; 11(1):785. PubMed ID: 32034145
[TBL] [Abstract][Full Text] [Related]
14. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ; Schiemann WP
Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.
Junk DJ; Cipriano R; Bryson BL; Gilmore HL; Jackson MW
Neoplasia; 2013 Sep; 15(9):1100-9. PubMed ID: 24027434
[TBL] [Abstract][Full Text] [Related]
16. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.
Galliher-Beckley AJ; Schiemann WP
Carcinogenesis; 2008 Feb; 29(2):244-51. PubMed ID: 18174260
[TBL] [Abstract][Full Text] [Related]
17. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M; Shintani Y; Wheelock MJ; Johnson KR
J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
[TBL] [Abstract][Full Text] [Related]
18. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
Neil JR; Johnson KM; Nemenoff RA; Schiemann WP
Carcinogenesis; 2008 Nov; 29(11):2227-35. PubMed ID: 18725385
[TBL] [Abstract][Full Text] [Related]
19. The relevance of the TGF-β Paradox to EMT-MET programs.
Morrison CD; Parvani JG; Schiemann WP
Cancer Lett; 2013 Nov; 341(1):30-40. PubMed ID: 23474494
[TBL] [Abstract][Full Text] [Related]
20. Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death.
Casey TM; Mulvey TM; Patnode TA; Dean A; Zakrzewska E; Plaut K
Exp Biol Med (Maywood); 2007 Sep; 232(8):1027-40. PubMed ID: 17720949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
